loading page

Modified novel management of cervical molar pregnancy and its related complications
  • +3
  • Manoj Kumar,
  • Manju Verma,
  • Uma Singh,
  • Rekha Sachan,
  • Pushpa Sankhwar,
  • Neera Kohli
Manoj Kumar
King George's Medical University

Corresponding Author:[email protected]

Author Profile
Manju Verma
King George's Medical University
Author Profile
Uma Singh
King George's Medical University
Author Profile
Rekha Sachan
King George's Medical University
Author Profile
Pushpa Sankhwar
King George's Medical University
Author Profile
Neera Kohli
King George's Medical University
Author Profile

Abstract

A-30-years-old-primigravida-patient with significant vaginal bleeding for 1-week following amenorrhea for 2-months and a positive pregnancy test. Duplex-US findings were suggesting cervical molar-pregnancy. Systemic methotrexate was administered as first-line therapy but necessitated dilatation-and-curettage followed by intracervical-diluted-vasopressin and adequate intracervical foley’s-balloon inflation to control bleeding but it was failed. Then, we resorted modified novel management of cervical molar pregnancy and its complications as uterine artery embolization with embologent gelfoam “slurry” soaked with methotrexate called trans-arterial-chemo-embolization (gTACE) for an immediate successful hemostatic measure to save the life and uterus of the patient suffering from rare manifestations of gestational trophoblastic disease.